Indian-made microspheres for inoperable liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests an affordable, Indian-made treatment for liver cancer (HCC) that can't be surgically removed. Tiny beads (microspheres) are injected into the liver's blood supply to directly deliver radiation to the tumor, potentially shrinking it and slowing the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your liver cancer should be inoperable and at an intermediate stage (called BCLC stage B).
- You need to have at least one liver tumor that is 5 cm or bigger on a scan.
- Your liver function must be good (not Child-Pugh class C) and you must not have cancer spread outside the liver.
- You need to be able to do most daily activities on your own (ECOG 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of biodegradable microsphere for treating liver cancer that cannot be removed with surgery. The microspheres are injected into the liver's blood supply to block tumors and deliver chemotherapy.
This trial tests a treatment called TheraSphere for people with liver cancer that hasn't responded to standard care or can't have it. TheraSphere uses tiny radioactive beads to target tumors in the liver, and this study is being done to get it approved in Japan.
This trial tests a combination of radioactive microspheres (Yttrium-90) with targeted immunotherapy drugs (camrelizumab and apatinib) for people with liver cancer (HCC) that cannot be surgically removed. It may be an option for those with intermediate-stage disease who haven't had prior systemic therapy.
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
This trial is testing a low 'scout' dose of tiny radioactive beads (resin microspheres) given into the liver to treat liver cancer. The goal is to see if this approach is safe and helps patients with certain types of liver cancer that cannot be surgically removed.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
Hear when a new Hepatecellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.